TOLEDO: Apomorphine Reduces Parkinson ' s ' Off ' Time TOLEDO: Apomorphine Reduces Parkinson ' s ' Off ' Time

Phase 3 TOLEDO trial results show that patients with PD given subcutaneous apomorphine infusion had significantly greater reductions in treatment ' off ' time than did those receiving placebo infusions.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news